PHA Celebrates our Research Grantees and Those Whose Generosity Empower their Work

As the heart of the pulmonary hypertension (PH) community, PHA is committed to providing support, education and empowerment programs to patients, caregivers, families and health care professionals. Another, equally important PHA priority is to invest in innovative research and young investigators, who will one day lead the field in finding a cure for PH.

May 25th, 2017|

Researchers Debate and Present Latest PH Research at 113th ATS Conference

The American Thoracic Society (ATS) annual conference has recently concluded, with a number of presentations in the latest research in lung-related diseases and disorders, including pulmonary hypertension (PH). As the longest-running large scale conference for respiratory medicine professionals in the world, the ATS annual conference brings together more than 17,000 attendees from more than 90 countries. ATS

May 25th, 2017|

Researchers to Present Studies Based on Data from PHA’s Accreditation Program Registry at the American Thoracic Society Meeting

Silver Spring, Md. (May 18, 2017) –  Researchers will present two abstracts based on information from the Pulmonary Hypertension Association Registry (PHAR) at the American Thoracic Society (ATS) meeting this month. The PHAR is a part of the Pulmonary Hypertension Association (PHA) Pulmonary Hypertension Care Center (PHCC) accreditation program. Pulmonary arterial hypertension (PAH)—a progressive,

May 18th, 2017|

PHA Accredits the First Regional Clinical Programs as Part of the Pulmonary Hypertension Care Center Program

Silver Spring, Md. (May 18, 2017) –  Three pulmonary hypertension (PH) clinics have earned accreditation from the Pulmonary Hypertension Association (PHA) after demonstrating their ability to deliver quality care to patients living with a complex, often misdiagnosed, life-threatening disease. The three centers were participants in the Regional Clinical Program (RCP) pilot program, designed as

May 18th, 2017|

Congress Approves 2 Billion Increase to NIH Budget

National Institutes of Health (NIH) grants support the work of pulmonary hypertension researchers across the county. Each year, PHA spends time on Capitol Hill talking with lawmakers about the importance of this research funding to help medical professionals better understand, and more effectively treat, PH. This spring, the President’s budget proposed a $1.2 billion cut

May 11th, 2017|

Accelerometry: Monitoring Physical Activity in Pediatric PAH Patients Using a Medical Device

The abundance of research that has been carried out on the management of WHO Group 1 PH (PAH, pulmonary arterial hypertension) in adults has led to many targeted treatment options. However, few randomized controlled trials are available to serve as a guide for treating children and adolescents with this disease. The lack of evidence-based

May 10th, 2017|

Article Introduces Chronic Thromboembolic Pulmonary Hypertension Overview

by Phyllis Hanlon, Contributing Writer WHO Group 4 PH (CTEPH, chronic thromboembolic pulmonary hypertension, a progressive and life-threatening condition, was the subject of a series of articles published in the July 2016 issue of the Annals of the American Thoracic Society. William R. Auger, MD, penned an introduction to the series that examined the articles,

April 27th, 2017|

Study Examines Genetic Link to Pulmonary Arterial Hypertension Outcomes

by Phyllis Hanlon, Contributing Writer  Genes act as information centers within each cell in the body, providing a personal and unique blueprint for every individual. They inform your hair and eye color, body type or shape and other characteristics. Genes are also responsible for diseases that are inherited from parents. For some individuals with pulmonary

April 7th, 2017|